The death domain kinase RIP mediates the TNF-induced NF-κB signal

Immunity

Volumn 8, Issue 3, 1998, Pages 297-303

  Kelliher, Michelle A ^b   Grimm, Stefan ^b   Ishida, Yasumasa ^b   Kuo, Frank ^a   Stanger, Ben Z ^b   Leder, Philip ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; GENE MUTATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; THYMOCYTE; TRANSCRIPTION REGULATION;

EID: 0032033132     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80535-X     Document Type: Article

References (43)

1. Baldwin, A.S. (1996). The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-681.
2. Baeuerle, P., and Baltimore, D. (1988). IκB: a specific inhibitor of the NF-κB transcription factor. Science 242, 540-546.
3. Baeuerle, P., and Henkel, T. (1994). Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-179.
4. Beg, A.A., and Baldwin, A.S. (1993). The I kappa B proteins: multifunctional regulators of Rel/NF-kappaB transcription factors. Genes Dev. 7, 2064-2070.
5. Beg, A.A., and Baltimore, D. (1996). An essential role for NF-κB in preventing TNF α-induced cell death. Science 274, 782-784.
6. Chinnaiyan, A.M., O'Rourke, K., Tewari, M., and Dixit, V.M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512.
7. Chinnaiyan, A.M., O'Rourke, K., Yu, G.L., Lyons, R.H., Garg, M., Duan, D.R., Xing, L., Gentz, R., Ni, J., and Dixit, V.M. (1996). Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274, 990-992.
8. Crowe, P.D., VanArsdale, T.L., Hession, C., Ehrenfels, B., Browning, J.L., Din, W.S., Goodwin, R.G., and Smith, C.A. (1994). A lymphotoxin-β-specific receptor. Science 264, 707-710.
9. Deng, C., Zhang, P., Harper, J.W., Elledge, S.J., and Leder, P. (1995). Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684.
10. DeTogni, P., Goellner, J., Ruddle, N.H., Streeter, P.R., Fick, A., Mariathasan, S., Smith, S.C., Carlson, R., Shornick, L.P., Strauss-Schoenberger, J., et al. (1994). Abnormal development of peripheral lymphoid organs deficient in lymphotoxin. Science 264, 703-707.
11. DiDonato, J.A., Hayakawa, M., Rothwarf, D.M., Zandi, E., and Karin, M. (1997). A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388, 548-554.
12. Duan, H., and Dixit, V.M. (1997). RAIDD is a new death adaptor molecule. Nature 385, 86-89.
13. Erickson, S.L., deSauvage, F.J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillett, N., Sheehan, K.C., Schreiber, R.D., Goeddel, D.V., and Moore, M.W. (1994). Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372, 560-563.
14. Grimm, S., Bauer, M.K.A., Baeuerle, P.A., and Schulze-Osthoff, K. (1988). Bcl-2 down-regulates the activity of transcription factor NF-κB induced apoptosis. J. Cell Biol. 134, 13-23.
15. Grimm, S., Stanger, B.Z., and Leder, P. (1996). RIP and FADD: two divergent "death domain"-containing proteins can induce apoptosis by convergent, but dissociable pathways. Proc. Natl. Acad. Sci. USA 93, 10923-10927.
16. Gupta, S., Campbell, D., Derijard, B., and Davis, R.J. (1995). Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267, 389-393.
17. Hsu, H., Xiong, J., and Goeddel, D.V. (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81, 495-504.
18. Hsu, H., Shu, H.B., Pan, M.G., and Goeddel, D.V. (1996a). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor signal transduction pathways. Cell 84, 299-308.
19. Hsu, H., Huang, J., Shu, H.B., Baichwal, V., and Goeddel, D.V. (1996b). TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387-396.
20. Kelliher, M.A., Seidin, D.C., and Leder, P. (1996). Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIα. EMBO J. 15, 5160-5166.
21. Kitson, J., Raven, T., Jiang, Y.P., Goeddel, D., Giles, K.M., Pun, K.T., Grinham, C.J., Brown, R., and Farrow, S.N. (1996). A death domain-containing receptor that mediates apoptosis. Nature 384, 372-375.
22. Koni, P.A., Sacca, R., Lawton, P., Browning, J.L., Ruddle, N.H., and Flavell, R.A. (1997). Distinct roles in lymphoid organogenesis for lymphotoxins α and β revealed in lymphotoxin β-deficient mice. Immunity 6, 491-500.
23. Lewis, M., Tartaglia, L.A., Lee, A., Bennett, G.L., Rice, G.C., Wong, G.H., Chen, E.Y., and Goeddel, D.V. (1991). Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 88, 2830-2834.
24. Liu, Z., Hsu, H., Goeddel, D.V., and Karin, M. (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565-576.
25. Malinin, N.L., Boldin, M.P., Kovalenko, A.V., and Wallach, D. (1997). MAP3K-related kinase involved in NF-kappa B induction by TNF, CD95 and IL-1. Nature 385, 540-544.
26. Marsters, S.A., Sheridan, J.P., Donahue, C.J., Pitti, R.M., Gray, C.L., Goddard, A.D., Bauer, K.D., and Ashkenazi, A. (1996). Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB. Curr. Biol. 6, 1669-1676.
27. Mercurio, F., Zhu, H., Murray, B.W., Shevchenko, A., Bennett, B., Li, J.W., Young, D., Barbosa, M., Mann, M., Manning, A., et al. (1997). IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278, 860-866.
28. Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., et al. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell 85, 817-827.
29. Nagata, S. (1997). Apoptosis by death factor. Cell 88, 355-365.
30. Pfeffer, K., Matsuyama, T., Kundig, T.M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P.S., Kronke, M., and Mak, T.W. (1993). Mice deficient for the 55 kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457-467.
31. Regnier, C.H., Song, H.Y., Gao, X., Goeddel, D.V., Cao, Z., and Rothe, M. (1997). Identification and characterization of an IκB kinase. Cell 90, 373-383.
32. Rothe, J., Lesslauer, W., Lotscher, Hansruedl, Lang, Y., Koebel, P., Kontgen, F., Althage, A., Zinkernagel, R., Steinmetz, M., et al. (1993). Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364, 798-802.
33. Stanger, B.Z., Leder, P., Lee, T.H., Kim, E., and Seed, B. (1995). RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81, 513-523.
34. Tartaglia, L., Rothe, M., Hu, Y.F., and Goeddel, D.V. (1993). Tumor necrosis factor's cytotoxicity activity is signaled by the p55 TNF receptor. Cell 73, 213-216.
35. Ting, A.T., Pimentel-Muinos, F.X., and Seed, B. (1996). RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis. EMBO J. 15, 6189-6196.
36. Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T., and Mulligan, R.C. (1991). Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163.
37. Wang, C.Y., Mayo, M.W., and Baldwin, A.S. (1996). TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274, 784-787.
38. Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R., and Verma, I.M. (1996). Suppression of TNFα-induced apoptosis by NF-κB. Science 274, 787-789.
39. Verma, I.M., Stevenson, J.K., Schwartz, E.M., Van Antwerp, D., and Miyamoto, S. (1995). Rel/NF-kappa B/Ikappa B family: intimate tales of association and dissociation. Genes Dev. 9, 2723-2735.
40. Woronicz, J.D., Gao, X., Cao, Z., Rothe, M., and Goeddel, D.V. (1997). IKappaB kinase-beta: NF-Kappa B activation and complex formation with IKappaB Kinase-alpha and NIK. Science 278, 866-869.
41. Xu, Y., Cheng, G., and Baltimore, D. (1996). Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity 5, 407-415.
42. Yeh, W.C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J.L., Ferrick, D., et al. (1997). Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7, 715-725.
43. Zandi, E., Rothwarf, D.M., Delhase, M., Hayakawa, M., and Karin, M. (1997). The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91, 243-252.